{
  "slug": "mindstate-design-labs",
  "name": "Mindstate Design Labs",
  "description": "Mindstate Design Labs is a biotechnology company building a closed-loop science and engineering stack for rational psychoactive effect design. They develop molecular-experience interfaces, such as Osmanthus, to link biology to human experience, transforming effects like clarity, presence, and motivation into quantitative design targets. Their clinical programs focus on decomposing, recombining, and synthesizing psychoactive effects for therapeutic applications, including the treatment of anhedonia in major depressive disorder.",
  "url": "https://optimly.ai/brand/mindstate-design-labs",
  "websiteUrl": "https://mindstate.design/",
  "logoUrl": "https://logo.clearbit.com/mindstate.design",
  "baiScore": 36.3,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Drug Discovery & Development Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-12T04:38:40.550Z",
  "verifiedVitals": {
    "website": "https://mindstate.design",
    "category": "Biotechnology",
    "what_it_does": "Mindstate Design Labs is building a closed-loop science and engineering stack for rational psychoactive effect design, developing molecular experience interfaces and clinical programs to decompose, recombine, and synthesize psychoactive effects for therapeutic applications.",
    "primary_audience": "Patients with conditions such as anhedonia in major depressive disorder, and more broadly, individuals seeking treatment for mental health conditions through precisely designed psychoactive effects.",
    "core_product": "Osmanthus, a molecular experience interface, and various drug development programs (e.g., MSD-001, MSD-101, MSD-102, MSD-103, MSD-201, MSD-202, MSD-203) focused on primer + probe fixed-dose combinations.",
    "parent_ownership": null
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1789979488487
}